← Back to Search

Bupivicaine Infusion for Postoperative Pain

N/A
Waitlist Available
Led By Steve S Chang, MD
Research Sponsored by Chang, Steve S., M.D.
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 24 hours
Awards & highlights

Study Summary

The investigators are testing to see if infusion of bupivicaine between the mesh and abdominal wall can reduce postoperative pain and decrease use of narcotics in the postoperative setting.

Eligible Conditions
  • Postoperative Pain

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~24 hours
This trial's timeline: 3 weeks for screening, Varies for treatment, and 24 hours for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Pain

Trial Design

1Treatment groups
Experimental Treatment
Group I: Bupivicaine InfusionExperimental Treatment1 Intervention
We will infuse bupivicaine between the abdominal wall and mesh to try and reduce postoperative pain

Find a Location

Who is running the clinical trial?

Chang, Steve S., M.D.Lead Sponsor
2 Previous Clinical Trials
197 Total Patients Enrolled
Steve S Chang, MDPrincipal InvestigatorSanta Barbara Cottage Hospital
2 Previous Clinical Trials
197 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
~6 spots leftby Apr 2025